Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Revenue |
| 49,463 | 53,944 | 70,320 | 90,737 | 81,122 |
Cost of revenue |
| -18,252 | -21,085 | -23,241 | -29,671 | -30,537 |
Gross Profit |
| 31,210 | 32,859 | 47,079 | 61,066 | 50,585 |
Sales, general & ad... |
| -12,492 | -14,637 | -17,854 | -21,108 | -23,460 |
Depreciation |
| -1,689 | -1,862 | -2,556 | -3,115 | -3,432 |
Provision |
| 0 | 0 | 0 | 0 | 0 |
Other op inc/exp... |
| 0 | 0 | 0 | 0 | 0 |
Operating income |
| 17,029 | 16,359 | 26,669 | 36,843 | 23,693 |
Profit before tax |
| 18,551 | 18,195 | 26,660 | 36,835 | 23,686 |
Net Income |
| 13,527 | 13,765 | 19,843 | 29,605 | 18,234 |
| | | | | ||
EPS Basic |
| 50.96 | 51.85 | 74.73 | 111.52 | 68.69 |